<SEC-DOCUMENT>0001209191-19-051309.txt : 20191001
<SEC-HEADER>0001209191-19-051309.hdr.sgml : 20191001
<ACCEPTANCE-DATETIME>20191001163719
ACCESSION NUMBER:		0001209191-19-051309
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190802
FILED AS OF DATE:		20191001
DATE AS OF CHANGE:		20191001

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Dagmar Dolby 2019 Trust BB,dated July 22, 2019
		CENTRAL INDEX KEY:			0001789808

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32431
		FILM NUMBER:		191129590

	BUSINESS ADDRESS:	
		STREET 1:		2515 SCOTT STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94115
		BUSINESS PHONE:		(415) 563-6947

	MAIL ADDRESS:	
		STREET 1:		2515 SCOTT STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94115

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dolby Laboratories, Inc.
		CENTRAL INDEX KEY:			0001308547
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				900199783
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0924

	BUSINESS ADDRESS:	
		STREET 1:		1275 MARKET STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
		BUSINESS PHONE:		415 558 0200

	MAIL ADDRESS:	
		STREET 1:		1275 MARKET STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2019-08-02</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001308547</issuerCik>
        <issuerName>Dolby Laboratories, Inc.</issuerName>
        <issuerTradingSymbol>DLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001789808</rptOwnerCik>
            <rptOwnerName>Dagmar Dolby 2019 Trust BB,dated July 22, 2019</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DOLBY LABORATORIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1275 MARKET STREET</rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94103</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Class B Common Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.00</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Class A Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>3700000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Shares of Class B Common Stock are convertible, at no cost, at any time at the election of the holder into shares of Class A Common Stock on a 1-for-1 basis.</footnote>
        <footnote id="F2">Reflects shares of Class B Common Stock (convertible into a like number of shares of Class A Common Stock) held of record by Dagmar Dolby as the Trustee of the Dagmar Dolby 2019 Trust BB, dated July 22, 2019 (the &quot;Dagmar Dolby 2019 Trust BB&quot;), dispositive power over which is held by Dagmar Dolby as the Trustee of the Dagmar Dolby 2019 Trust BB and voting power over which is held by David E. Dolby, son of Dagmar Dolby, as Special Trustee of the Dagmar Dolby 2019 Trust BB.</footnote>
    </footnotes>

    <remarks>Exhibit Index
Exhibit 24.1 Power of Attorney of Dagmar Dolby 2019 Trust BB</remarks>

    <ownerSignature>
        <signatureName>/s/ Daniel Rodriguez, Attorney-in-fact</signatureName>
        <signatureDate>2019-10-01</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.3_874139
<SEQUENCE>2
<FILENAME>poa.txt
<DESCRIPTION>POA DOCUMENT
<TEXT>
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Andy Sherman, Daniel Rodriguez, Morrison & Foerster LLP
and Shartsis Friese LLP, signing singly, the undersigned's true and lawful
attorney-in-fact to:

	(1)	execute for and on behalf of the undersigned statements on Schedule 13D or
Schedule 13G, and Forms ID, 3,4 and 5, in accordance with Section 13 or Section
16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder;
	(2)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such statement on
Schedule 13D or Schedule 13G, or Form ID, 3, 4 or 5, including any electronic
filing thereof, complete and execute any amendment or amendments thereto, and
timely file such form with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
	(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-facts' discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever necessary or
proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming any
of the undersigned's responsibilities to comply with Section 13 or Section 16 of
the Securities Exchange Act of 1934, as amended, and the rules thereunder.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file statements on Schedule 13D or Schedule
13G, or Form ID, 3, 4 and 5, with respect to the undersigned's holdings of and
transactions in securities issued by Dolby Laboratories, Inc., unless earlier
revoked by the undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of July 22, 2019.

Dagmar Dolby 2019 Trust BB, dated July 22, 2019

/s/ Dagmar Dolby
By:	Dagmar Dolby
Title:	Trustee

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
